QTZM Stock Overview
A biotransformation company, focused on green chemistry. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Quantumzyme Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.00 |
52 Week High | US$1.00 |
52 Week Low | US$1.00 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
QTZM | US Commercial Services | US Market | |
---|---|---|---|
7D | 0% | 0.05% | 0.2% |
1Y | n/a | 21.7% | 22.0% |
Return vs Industry: Insufficient data to determine how QTZM performed against the US Commercial Services industry.
Return vs Market: Insufficient data to determine how QTZM performed against the US Market.
Price Volatility
QTZM volatility | |
---|---|
QTZM Average Weekly Movement | n/a |
Commercial Services Industry Average Movement | 7.2% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 18.6% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: QTZM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine QTZM's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | Naveen Kulkarni | n/a |
Quantumzyme Corp. is a biotransformation company, focused on green chemistry. It utilizes customers research to enhance enzyme activity, selectivity, and specificity by applying quantum mechanics, molecular modeling, and engineering approaches. The focused approach to aid all chemical companies to harness the power of technology by simplifying complex chemistry and reducing the number of steps by implementing scientific rationale like quantum mechanics in biology.
Quantumzyme Corp. Fundamentals Summary
QTZM fundamental statistics | |
---|---|
Market cap | US$34.78m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs QTZM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
QTZM income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did QTZM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/07 20:22 |
End of Day Share Price | 2024/11/20 00:00 |
Earnings | N/A |
Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Quantumzyme Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.